Hong Kong Pharmaceuticals & Biotech Upcoming Dividends

Tong Ren Tang Technologies

Market Cap: HK$4.4b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Jacobson Pharma

Market Cap: HK$2.1b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

Pak Fah Yeow International

Market Cap: HK$740.1m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

JBM (Healthcare)

Market Cap: HK$1.6b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.